Tempus to Present Four Abstracts at ESMO 2024
Tempus AI, Inc. (NASDAQ: TEM), a leader in using AI for precision medicine, has announced that four of its abstracts have been accepted for the European Society for Medical Oncology…
Category News
Read MoreTempus to Present Four Abstracts at ESMO 2024
Rising Pharmaceuticals Launches Edetate Calcium Disodium Injection in the U.S.
Rising Pharmaceuticals, Inc. has announced the commercial launch of Edetate calcium disodium injection. Despite a current shortage of this product in the U.S., Rising’s version remains available. Rising Pharmaceuticals, Inc.…
GN BODYDOCTOR Kegel Exerciser: Effective for Pelvic Muscle Health
As people age or experience life events like childbirth, maintaining pelvic muscle strength can be challenging. While Kegel exercises are a well-known solution, they are often overlooked. Developed by Dr.…
ENHERTU® Shows Strong Clinical Activity in HER2+ Metastatic Breast Cancer with Brain Metastases
Results from the DESTINY-Breast12 phase 3b/4 trial reveal that ENHERTU® (trastuzumab deruxtecan) demonstrated significant clinical activity in HER2-positive metastatic breast cancer patients with brain metastases who had received up to…
Spencer Health Solutions Earns ISO 27001 Certification
Spencer Health Solutions (SHS), a leader in intelligent medication management technology, has announced its achievement of ISO 27001:2022 certification. This esteemed accreditation highlights SHS’s dedication to safeguarding patient data and…
Contraline & Population Council Strike Deal for Innovative Male Contraceptive
Contraline, Inc., a clinical-stage biotechnology firm, has signed an exclusive option-to-license agreement with the Population Council for the Nestorone/Testosterone Transdermal Gel (NES/T) for male contraception. If the option is exercised,…
Paragon 28 Unveils New Right-Angle Drill for APEX 3D™ Ankle Replacement System
Paragon 28, Inc. (NYSE: FNA) is excited to introduce a new Right-Angle Drill for its APEX 3D™ Total Ankle Replacement System. This innovative tool is designed to enhance tibia preparation…
Delta-Fly Pharma Begins Phase I/II Study of DFP-10917 with Venetoclax in AML Patients
Following our April 8, 2024, announcement, we’re excited to provide an update on our progress. The U.S. Food and Drug Administration (FDA) approved a Phase I/II clinical trial for DFP-10917…
Day 2 of 11th Annual World Patient Safety Summit Focuses on Collaboration and Advanced Tech
On the second day of the 11th Annual World Patient Safety, Science & Technology Summit, hosted by the Patient Safety Movement Foundation (PSMF) at UC Irvine, the focus was on…
Daiichi Sankyo Addresses Healthcare Gaps and Unmet Needs in Cardiovascular Care
Daiichi Sankyo Europe (Daiichi Sankyo) has announced an enhanced commitment to tackling significant gaps in cardiovascular care, focusing on disparities in treatment and outcomes among different patient groups. This renewed…
Arrowhead Presents Phase 3 PALISADE Study Data on Plozasiran at ESC 2024
Arrowhead Pharmaceuticals, Inc. (NASDAQ: ARWR) announced today the results of the Phase 3 PALISADE study evaluating investigational plozasiran in patients with familial chylomicronemia syndrome (FCS), a rare and severe genetic…
Updated Flu and COVID-19 Shots Now at CVS Pharmacy® and MinuteClinic®
CVS Pharmacy® (NYSE: CVS) has announced that the updated 2024-2025 flu and COVID-19 vaccines are now available at CVS Pharmacy and MinuteClinic® locations nationwide. Patients can walk in for a…